You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Boehringer Ingelheim
McKinsey
Medtronic
Merck

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

TRIAMTERENE AND HYDROCHLOROTHIAZIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Triamterene And Hydrochlorothiazide, and what generic alternatives are available?

Triamterene And Hydrochlorothiazide is a drug marketed by Ani Pharms Inc, Cadila, Chartwell Rx, Duramed Pharms Barr, Lannett Co Inc, Mylan, Novartis, Sandoz, Vitarine, Am Therap, Apotex Inc, Pliva, Quantum Pharmics, Watson Labs, and Zydus Pharms. and is included in twenty-one NDAs.

The generic ingredient in TRIAMTERENE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.

Summary for TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for TRIAMTERENE AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
West China HospitalPhase 4
Vanderbilt UniversityN/A
VA Office of Research and DevelopmentN/A

See all TRIAMTERENE AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for TRIAMTERENE AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for TRIAMTERENE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 074970-001 Jan 6, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene TABLET;ORAL 072011-001 Jun 17, 1988 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 074701-001 Jun 7, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKesson
Medtronic
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.